Gregory A. Yanik

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease”.

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Blood Advances(2023)10.1182/bloodadvances.2023009853

N/A

0.794DataRank · unranked

25 citations

Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra +32 more

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0095

N/A

0.785DataRank · unranked

186 citations

Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed, Susana Rives +17 more

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.006

N/A

0.529DataRank · unranked

33 citations

Arlene Naranjo, Rochelle Bagatell, Steven G. DuBois, Jeannine S. McCune, Sheena C. Tenney +17 more

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30418

N/A

0.360DataRank · unranked

10 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.001

N/A

0.269DataRank · unranked

5 citations

Felipe Soto, Cheuk Hong Leung, Neel Bhan, Lara Bashoura, Burton F. Dickey +16 more

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Blood Advances(2025)10.1182/bloodadvances.2025016122

N/A

0.241DataRank · unranked

4 citations

Carson Moss, Zayan Musa, Alexander Bell, Christian O’Donnell, Carlos Hernandez Borges +8 more

Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.024

N/A

0.208DataRank · unranked

3 citations

Kwang Woo Ahn, Kyle Hebert, Rasha Atshan, Donna A. Wall, Kanhatai Chiengthong +20 more

Development and validation of a pediatric disease risk index for allogeneic hematopoietic cell transplantation.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7503

N/A

0.165DataRank · unranked

2 citations

Carrie L. Kitko, Kwang Woo Ahn, Mariam H Johnson, Kirk R. Schultz, Angela R. Smith +3 more

Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.012

N/A

0DataRank · unranked

11 citations

William A. Gower, Kenneth R. Cooke, Anne Bergeron, Kirk R. Schultz, Amisha V. Barochia +23 more

CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant

Blood Advances(2024)10.1182/bloodadvances.2024013748

N/A

0DataRank · unranked

5 citations

Christopher Bertini, Mansour Alkhunaizi, Maria Paulina Hernandez, Zayan Musa, Carlos Hernandez Borges +22 more

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.03.030

N/A

0DataRank · unranked

0 citations

Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert, Kayla Betz +21 more

Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.06.020

N/A

0DataRank · unranked

1 citations

Ziyi Wang, Luis Gustavo Costa da Rocha, Breanna Jones, Robert R. Jenq, Chia‐Chi Chang +19 more

Interpretation of response in BOS: the definitions remain key

Blood Advances(2025)10.1182/bloodadvances.2025015948

N/A

0DataRank · unranked

0 citations

Vibha N. Lama, Kenneth R. Cooke, Gregory A. Yanik, Kirsten M. Williams

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Blood Advances(2021)10.1182/bloodadvances.2021005208

N/A

0DataRank · unranked

33 citations

Benjamin Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz, Sung Won Choi +19 more

Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis

Translational Oncology(2022)10.1016/j.tranon.2022.101428

N/A

0DataRank · unranked

9 citations

David Karnak, Ming Tang, Ralph Jiang, Yi Luo, Philip S. Boonstra +17 more

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10027

N/A

0DataRank · unranked

0 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885

N/A

0DataRank · unranked

42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more

Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

American Journal of Transplantation(2020)10.1111/ajt.15814

N/A

0DataRank · unranked

44 citations

Katherine Selwa, Charles R. Hatt, Sundaresh Ram, Aleksa B. Fortuna, Margaret Guerriero +17 more

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma

Bone Marrow Transplantation(2023)10.1038/s41409-023-02092-3

N/A

0DataRank · unranked

3 citations

Kwang Woo Ahn, Kyle Hebert, Rasha Atshan, Donna A. Wall, Kanhatai Chiengthong +22 more